|
US3906092A
(en)
*
|
1971-11-26 |
1975-09-16 |
Merck & Co Inc |
Stimulation of antibody response
|
|
GB2134869A
(en)
|
1983-02-15 |
1984-08-22 |
Squibb & Sons Inc |
Method of preparing liposomes and products produced thereby
|
|
US4610868A
(en)
*
|
1984-03-20 |
1986-09-09 |
The Liposome Company, Inc. |
Lipid matrix carriers for use in drug delivery systems
|
|
US6090406A
(en)
*
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US5897873A
(en)
*
|
1984-04-12 |
1999-04-27 |
The Liposome Company, Inc. |
Affinity associated vaccine
|
|
US5550289A
(en)
|
1985-01-07 |
1996-08-27 |
Syntex (U.S.A.) Inc. |
N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4806352A
(en)
*
|
1986-04-15 |
1989-02-21 |
Ribi Immunochem Research Inc. |
Immunological lipid emulsion adjuvant
|
|
US4803070A
(en)
*
|
1986-04-15 |
1989-02-07 |
Ribi Immunochem Research Inc. |
Immunological emulsion adjuvants for polysaccharide vaccines
|
|
US4806350A
(en)
*
|
1986-04-18 |
1989-02-21 |
Norden Laboratories, Inc. |
Vaccine formulation
|
|
US5084269A
(en)
*
|
1986-11-06 |
1992-01-28 |
Kullenberg Fred W |
Adjuvant for dose treatment with antigens
|
|
US4920016A
(en)
*
|
1986-12-24 |
1990-04-24 |
Linear Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US6093406A
(en)
*
|
1988-06-02 |
2000-07-25 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccine for induction of immunity to malaria
|
|
WO1990014837A1
(en)
*
|
1989-05-25 |
1990-12-13 |
Chiron Corporation |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
FR2649013B1
(fr)
*
|
1989-07-03 |
1991-10-25 |
Seppic Sa |
Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
|
|
US5015476A
(en)
*
|
1989-08-11 |
1991-05-14 |
Paravax, Inc. |
Immunization implant and method
|
|
US5013556A
(en)
*
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
IE904098A1
(en)
*
|
1989-11-13 |
1991-05-22 |
Nova Pharm Corp |
Lipospheres for controlled delivery of substances
|
|
US5091188A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
AU657907B2
(en)
|
1990-05-29 |
1995-03-30 |
Wyeth Holdings Corporation |
Mycoplasma hyopneumoniae vaccine
|
|
US5709879A
(en)
*
|
1990-06-29 |
1998-01-20 |
Chiron Corporation |
Vaccine compositions containing liposomes
|
|
WO1992000081A1
(en)
|
1990-06-29 |
1992-01-09 |
Chiron Corporation |
Vaccine compositions containing liposomes
|
|
JPH06503559A
(ja)
|
1990-12-12 |
1994-04-21 |
ザ・ユニバーシティ・オブ・クイーンズランド |
サブユニット・パピローマウイルス・ワクチンおよびそれに使用するペプチド
|
|
CA2072249C
(en)
|
1991-06-28 |
2003-06-17 |
Saiko Hosokawa |
Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
|
|
CZ28294A3
(en)
|
1991-08-13 |
1994-05-18 |
Biotech Australia Pty Ltd |
Immunostimulation
|
|
US6037135A
(en)
*
|
1992-08-07 |
2000-03-14 |
Epimmune Inc. |
Methods for making HLA binding peptides and their uses
|
|
FI944052A0
(fi)
|
1992-03-03 |
1994-09-02 |
Daiichi Seiyaku Co |
Oraalinen rokote
|
|
US5855894A
(en)
*
|
1992-03-30 |
1999-01-05 |
Pfizer Inc. |
Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
|
|
US5736141A
(en)
*
|
1992-06-05 |
1998-04-07 |
Dalhousie University |
Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant
|
|
AU4303493A
(en)
|
1992-06-05 |
1994-01-04 |
University Of Dalhousie |
Use of zona pellucida glycoproteins for immunocontraception
|
|
USRE37224E1
(en)
*
|
1992-06-05 |
2001-06-12 |
Dalhousie University |
Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant
|
|
SI9300468A
(en)
*
|
1992-10-14 |
1994-06-30 |
Hoffmann La Roche |
Injectable composition for the sustained release of biologically active compounds
|
|
US5820879A
(en)
*
|
1993-02-12 |
1998-10-13 |
Access Pharmaceuticals, Inc. |
Method of delivering a lipid-coated condensed-phase microparticle composition
|
|
JPH06247842A
(ja)
*
|
1993-02-23 |
1994-09-06 |
Green Cross Corp:The |
リポソーム組成物の製造方法
|
|
WO1995004542A1
(en)
|
1993-08-06 |
1995-02-16 |
Cytel Corporation |
Cloning and characterization of the complete mage-1 gene
|
|
US20050049197A1
(en)
|
1993-09-14 |
2005-03-03 |
Epimmune Inc. |
Induction of immune response against desired determinants
|
|
JP3836874B2
(ja)
|
1994-02-24 |
2006-10-25 |
ノババックス インコーポレイテッド |
免疫アジュバントとして少ラメラ脂質小胞を含むワクチン
|
|
US5874560A
(en)
|
1994-04-22 |
1999-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Melanoma antigens and their use in diagnostic and therapeutic methods
|
|
WO1995031480A1
(en)
|
1994-05-18 |
1995-11-23 |
S.P.I. Synthetic Peptides Incorporated |
Heterodimer polypeptide immunogen carrier composition and method
|
|
WO1995033835A1
(en)
*
|
1994-06-02 |
1995-12-14 |
Chiron Corporation |
Nucleic acid immunization using a virus-based infection/transfection system
|
|
US5688772A
(en)
|
1994-08-01 |
1997-11-18 |
University Of Saskatchewan |
Quinoa saponin compositions and methods of use
|
|
US5637300A
(en)
*
|
1994-08-03 |
1997-06-10 |
Dunbar; Bonnie S. |
Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in contraception
|
|
US6355256B1
(en)
|
1994-09-30 |
2002-03-12 |
Ludwig Institute For Cancer Research |
Compositions containing a p53 derived protein or peptide, an adjuvant, and interleukin-12 and uses thereof
|
|
FR2726764B1
(fr)
*
|
1994-11-14 |
1997-01-31 |
Pasteur Merieux Serums Vacc |
Adjuvant pour composition vaccinale
|
|
GB9422990D0
(en)
|
1994-11-15 |
1995-01-04 |
Cortecs Ltd |
Immunogenic compositions
|
|
FR2732895B1
(fr)
*
|
1995-04-11 |
1997-05-16 |
Pasteur Merieux Serums Vacc |
Utilisation d'un compose amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
|
|
US6846489B1
(en)
*
|
1995-04-25 |
2005-01-25 |
Smithkline Beecham Biologicals S.A. |
Vaccines containing a saponin and a sterol
|
|
US5705151A
(en)
*
|
1995-05-18 |
1998-01-06 |
National Jewish Center For Immunology & Respiratory Medicine |
Gene therapy for T cell regulation
|
|
AU6330896A
(en)
*
|
1995-06-07 |
1996-12-30 |
Governors Of The University Of Alberta, The |
A method for eliciting a th1-specific immune response
|
|
JP3098401B2
(ja)
|
1995-07-12 |
2000-10-16 |
株式会社エルティーティー研究所 |
経鼻投与用製剤
|
|
US6096313A
(en)
*
|
1996-02-09 |
2000-08-01 |
Ludwig Institute For Cancer Research |
Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
|
|
US5840839A
(en)
|
1996-02-09 |
1998-11-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
|
|
US7019112B1
(en)
*
|
1996-03-19 |
2006-03-28 |
University Of Virginia Patent Foundation |
Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses therefor
|
|
EP0928136B1
(en)
*
|
1996-06-05 |
2003-10-22 |
Ashmont Holdings Limited |
Injectable compositions
|
|
US5919480A
(en)
*
|
1996-06-24 |
1999-07-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Liposomal influenza vaccine composition and method
|
|
US6284267B1
(en)
*
|
1996-08-14 |
2001-09-04 |
Nutrimed Biotech |
Amphiphilic materials and liposome formulations thereof
|
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
|
US20060002949A1
(en)
*
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
|
US5910306A
(en)
*
|
1996-11-14 |
1999-06-08 |
The United States Of America As Represented By The Secretary Of The Army |
Transdermal delivery system for antigen
|
|
CA2203843C
(en)
*
|
1997-04-28 |
2013-07-23 |
Her Majesty The Queen, In Right Of Canada, As Represented By The Ministe R Of National Defence |
Liposome-encapsulated poly iclc
|
|
US6080725A
(en)
*
|
1997-05-20 |
2000-06-27 |
Galenica Pharmaceuticals, Inc. |
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
|
|
US6110492A
(en)
*
|
1997-05-28 |
2000-08-29 |
Jenner Biotherapies, Inc. |
Immunogenic compositions
|
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
AU8921698A
(en)
*
|
1997-08-29 |
1999-03-16 |
Human Genome Sciences, Inc. |
Follistatin-3
|
|
GB9718901D0
(en)
*
|
1997-09-05 |
1997-11-12 |
Smithkline Beecham Biolog |
Vaccine
|
|
US6291430B1
(en)
*
|
1997-09-12 |
2001-09-18 |
Ludwig Institute For Cancer Research |
Mage-3 peptides presented by HLA class II molecules
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
US6183746B1
(en)
*
|
1997-10-09 |
2001-02-06 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
|
AUPP060097A0
(en)
*
|
1997-11-28 |
1998-01-08 |
Commonwealth Scientific And Industrial Research Organisation |
Adjuvant system for enhanced response
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
PT1042001E
(pt)
*
|
1997-12-16 |
2002-09-30 |
Chiron Corp |
Uso de microparticulas combinadas com emulsoes submicronicas oleo-em-agua
|
|
US6218371B1
(en)
|
1998-04-03 |
2001-04-17 |
University Of Iowa Research Foundation |
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
|
|
US6588671B2
(en)
|
1998-04-09 |
2003-07-08 |
Dcard, Inc. |
Positioning of a recording head for a data storage device
|
|
SE9801288D0
(sv)
*
|
1998-04-14 |
1998-04-14 |
Astra Ab |
Vaccine delivery system and metod of production
|
|
US6472375B1
(en)
*
|
1998-04-16 |
2002-10-29 |
John Wayne Cancer Institute |
DNA vaccine and methods for its use
|
|
US6632447B1
(en)
|
1998-05-07 |
2003-10-14 |
The University Of Tennessee Research Corporation |
Method for chemoprevention of prostate cancer
|
|
CA2330610A1
(en)
*
|
1998-05-07 |
1999-11-11 |
Corixa Corporation |
Adjuvant composition and methods for its use
|
|
GB9810236D0
(en)
*
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
|
US6406719B1
(en)
*
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
|
ATE480566T1
(de)
*
|
1998-06-15 |
2010-09-15 |
Quest Pharmatech Inc |
Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs
|
|
US20030044454A1
(en)
*
|
1998-06-30 |
2003-03-06 |
Masaru Fukui |
Compositions containing liposomes and/or emulsions and process for the preparation thereof
|
|
FR2781160B1
(fr)
*
|
1998-07-03 |
2000-08-18 |
Pasteur Merieux Serums Vacc |
Utilisation d'un compose amphipathique pour adjuver un vaccin sous-unitaire
|
|
US6956021B1
(en)
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
|
US7087236B1
(en)
*
|
1998-09-01 |
2006-08-08 |
Merrion Research I Limited |
Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
|
|
US20050084524A1
(en)
*
|
1998-09-30 |
2005-04-21 |
Alza Corporation |
Method for potentiating activity of a chemotherapeutic drug
|
|
US6787154B2
(en)
*
|
1998-10-20 |
2004-09-07 |
Salvatore Albani |
Artificial antigen presenting cells
|
|
GB2345010B
(en)
|
1998-12-17 |
2002-12-31 |
Electrosols Ltd |
A delivery device
|
|
AU1765300A
(en)
|
1998-12-22 |
2000-07-12 |
Dalhousie University |
Compositions and methods for reducing or preventing fertilization in fish and birds
|
|
US6790457B1
(en)
*
|
1998-12-22 |
2004-09-14 |
Dalhousie University |
Compositions and methods for reducing or preventing fertilization in fish and birds
|
|
AU769539B2
(en)
*
|
1999-01-29 |
2004-01-29 |
Zoetis Services Llc |
Adjuvants for use in vaccines
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
DK1187629T3
(da)
*
|
1999-04-19 |
2005-01-17 |
Glaxosmithkline Biolog Sa |
Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
|
|
ID30407A
(id)
|
1999-05-13 |
2001-11-29 |
American Cyanamid Co |
Formulasi-formulasi kombinasi bahan penambah
|
|
WO2000071671A2
(en)
|
1999-05-26 |
2000-11-30 |
New York University |
New mutant genes in familial british dementia and familial danish dementia
|
|
AU763945B2
(en)
|
1999-06-04 |
2003-08-07 |
Skyepharma Inc. |
Oil-core compositions for the sustained release of hydrophobic drugs
|
|
GB9923176D0
(en)
*
|
1999-09-30 |
1999-12-01 |
Smithkline Beecham Biolog |
Novel composition
|
|
ATE454901T1
(de)
|
1999-10-13 |
2010-01-15 |
Novartis Vaccines & Diagnostic |
Verfahren zur erhaltung zellimmuneantworten gegen proteinen
|
|
US6605696B1
(en)
*
|
1999-10-22 |
2003-08-12 |
Pfizer, Inc. |
Lawsonia intracellularis proteins, and related methods and materials
|
|
US6511676B1
(en)
*
|
1999-11-05 |
2003-01-28 |
Teni Boulikas |
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
|
|
US6248353B1
(en)
|
1999-12-10 |
2001-06-19 |
Dade Behring Inc. |
Reconstitution of purified membrane proteins into preformed liposomes
|
|
US7026443B1
(en)
|
1999-12-10 |
2006-04-11 |
Epimmune Inc. |
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
|
|
US6602510B1
(en)
|
2000-04-05 |
2003-08-05 |
Epimmune Inc. |
HLA class I A2 tumor associated antigen peptides and vaccine compositions
|
|
US6228648B1
(en)
*
|
2000-03-17 |
2001-05-08 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of ADAM10 expression
|
|
JP2003528068A
(ja)
|
2000-03-17 |
2003-09-24 |
コリクサ コーポレイション |
新規両親媒性アルデヒドならびにアジュバントおよび免疫エフェクターとしてのそれらの使用
|
|
US7449557B2
(en)
|
2000-06-02 |
2008-11-11 |
University Of Connecticut Health Center |
Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
|
|
AT410173B
(de)
|
2000-06-08 |
2003-02-25 |
Cistem Biotechnologies Gmbh |
Antigene zusammensetzung
|
|
DE60117164T2
(de)
*
|
2000-11-07 |
2006-08-03 |
Immuno Vaccine Technologies Inc., Halifax |
Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
|
|
DE60134265D1
(de)
|
2000-12-01 |
2008-07-10 |
Biomira Inc |
Herstellung grosser liposome durch infusion in peg
|
|
ES2724121T3
(es)
|
2000-12-08 |
2019-09-06 |
Academisch Ziekenhuis Leiden |
Péptidos largos de 22-45 residuos de aminoácidos que inducen y/o mejoran las respuestas inmunológicas específicas para antígenos
|
|
US20030045467A1
(en)
*
|
2001-01-05 |
2003-03-06 |
Tihamer Orban |
Autoantigen composition
|
|
US6497896B2
(en)
|
2001-02-12 |
2002-12-24 |
Supergen, Inc. |
Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin
|
|
CN1168740C
(zh)
*
|
2001-04-04 |
2004-09-29 |
上海美恩生物技术有限公司 |
细胞因子基因修饰的抗原提呈细胞/肿瘤细胞偶联物、其制法和用途
|
|
US6676958B2
(en)
*
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
|
WO2003009870A1
(en)
*
|
2001-07-25 |
2003-02-06 |
Mitsubishi Pharma Corporation |
Remedies for mammary cancer
|
|
CA2454750C
(en)
*
|
2001-07-31 |
2012-09-18 |
David M. Koelle |
Immunologically significant herpes simplex virus antigens and methods for using same
|
|
GB0127564D0
(en)
*
|
2001-11-16 |
2002-01-09 |
Medical Res Council |
Emulsion compositions
|
|
US6517816B1
(en)
|
2001-12-26 |
2003-02-11 |
Avon Products, Inc. |
Sunscreen emulsion composition and method of use
|
|
US7056515B2
(en)
*
|
2002-02-08 |
2006-06-06 |
Immunovaccine Technologies Inc. |
Antigens for immunocontraception
|
|
EP1474447A2
(en)
|
2002-02-08 |
2004-11-10 |
Immunovaccine Technologies Inc. |
Antigens for immunocontraception
|
|
US20030220284A1
(en)
|
2002-02-22 |
2003-11-27 |
Patricia Yotnda |
Delivery of adenoviral DNA in a liposomal formulation for treatment of disease
|
|
AU2003277865B2
(en)
|
2002-06-25 |
2008-08-21 |
City Of Hope |
Adjuvant-free peptide vaccine
|
|
US20040213837A1
(en)
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
|
CN1289142C
(zh)
*
|
2002-08-09 |
2006-12-13 |
中国科学院上海生命科学研究院 |
含sa脂质体作为药物载体的药物新剂型
|
|
WO2004017944A1
(en)
|
2002-08-23 |
2004-03-04 |
Neopharm, Inc. |
Liposomal gemcitabine compositions for better drug delivery
|
|
EP1393720A1
(en)
*
|
2002-08-27 |
2004-03-03 |
Universiteit Utrecht |
Vesicle-encapsulated corticosteroids for treatment of cancer
|
|
US7179645B2
(en)
|
2002-09-24 |
2007-02-20 |
Antigen Express, Inc. |
Ii-Key/antigenic epitope hybrid peptide vaccines
|
|
DE10249401A1
(de)
|
2002-10-23 |
2004-05-13 |
Bernina Biosystems Gmbh |
Liposomen formende Zusammensetzung
|
|
US20050158375A1
(en)
*
|
2002-11-15 |
2005-07-21 |
Toshikiro Kimura |
Pharmaceutical composition containing liposomes for treating cancer
|
|
AU2003296330A1
(en)
|
2002-12-10 |
2004-06-30 |
Epimmune Inc. |
Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions
|
|
DK1992635T3
(da)
|
2002-12-23 |
2012-03-05 |
Dynavax Tech Corp |
Oligonukleotider med immunstimulatorisk sekvens og fremgangsmåder til anvendelse af disse
|
|
EP2263687B1
(en)
|
2002-12-27 |
2015-03-25 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogenic compositions containing phospholipid
|
|
US20040223977A1
(en)
|
2003-02-03 |
2004-11-11 |
City Of Hope |
Fusion peptide HIV vaccines
|
|
KR20050105455A
(ko)
|
2003-02-11 |
2005-11-04 |
네오팜 인코포레이티드 |
리포좀 제제의 제조 방법
|
|
DE602004027714D1
(de)
*
|
2003-04-02 |
2010-07-29 |
Univ Texas |
Anti-tumor effekt von bik-mutanten
|
|
RU2541809C2
(ru)
|
2003-04-04 |
2015-02-20 |
Зоетис Пи ЛЛК |
Микрофлюидизированные эмульсии "масло в воде" и композиции вакцины
|
|
SI1620456T1
(sl)
|
2003-04-18 |
2014-05-30 |
Biotech Synergy, Inc. |
Hla-a2 s tumorjem povezan antigen peptidov in sestavki
|
|
US20050002999A1
(en)
*
|
2003-06-04 |
2005-01-06 |
Rahul Mehta |
Long-circulating liposomal compositions
|
|
US20050013812A1
(en)
|
2003-07-14 |
2005-01-20 |
Dow Steven W. |
Vaccines using pattern recognition receptor-ligand:lipid complexes
|
|
AU2004267506A1
(en)
|
2003-08-26 |
2005-03-03 |
Board Of Regents, The University Of Texas System |
Anti-cancer vaccines
|
|
US20050220781A1
(en)
|
2003-09-04 |
2005-10-06 |
Duen-Hwa Yan |
IFIX, a novel HIN-200 protein, for cancer therapy
|
|
GB0321615D0
(en)
|
2003-09-15 |
2003-10-15 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
GB0323965D0
(en)
*
|
2003-10-13 |
2003-11-19 |
Glaxosmithkline Biolog Sa |
Immunogenic compositions
|
|
US20050266066A1
(en)
|
2003-10-20 |
2005-12-01 |
Nof Corporation |
Phospholipid membrane preparation
|
|
US20050175683A1
(en)
*
|
2003-10-24 |
2005-08-11 |
Yuanpeng Zhang |
Preparation of lipid particles
|
|
ES2329374T3
(es)
*
|
2003-11-14 |
2009-11-25 |
Het Nederlands Kanker Instituut (The Netherlands Cancer Institute) |
Formulaciones farmaceuticas que utilizan esfingolipidos de cadena corta y usos de las mismas.
|
|
EP1550458A1
(en)
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
|
EP1732598A4
(en)
|
2003-12-31 |
2009-08-26 |
Pharmexa Inc |
TRIGGERING CELLULAR IMMUNE RESPONSES TO THE HUMAN PAPILLOVIRUS USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS
|
|
JP2007522119A
(ja)
|
2004-01-28 |
2007-08-09 |
キュリックス エーピーエス |
アミロイド関連疾患用ワクチンとしてのアミロイドタンパク質のコンジュゲート
|
|
EP1737966B1
(en)
|
2004-04-02 |
2012-05-09 |
Board of Regents, The University of Texas System |
Cancer specific promoters
|
|
KR20110132416A
(ko)
|
2004-04-05 |
2011-12-07 |
화이자 프로덕츠 인코포레이티드 |
미세유체화된 수중유 유화액 및 백신 조성물
|
|
GB0408164D0
(en)
*
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
|
CA2563533C
(en)
|
2004-04-15 |
2013-10-01 |
Shmuel A. Ben-Sasson |
Compositions capable of facilitating penetration across a biological barrier
|
|
AU2005251691A1
(en)
*
|
2004-05-17 |
2005-12-22 |
Tekmira Pharmaceuticals Corporation |
Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
|
|
WO2006050155A2
(en)
|
2004-10-29 |
2006-05-11 |
Biomune, Inc. |
Cancer therapeutic compositions
|
|
US8337815B2
(en)
|
2004-12-23 |
2012-12-25 |
Discovery Laboratories, Inc. |
Pulmonary surfactant formulations
|
|
CA2592922A1
(en)
|
2004-12-29 |
2006-07-06 |
Mannkind Corporation |
Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
|
|
US8895717B2
(en)
*
|
2005-04-15 |
2014-11-25 |
The Board Of Regents Of The University Of Texas System |
Delivery of siRNA by neutral lipid compositions
|
|
US20060275777A1
(en)
|
2005-06-03 |
2006-12-07 |
Waelti Ernst R |
Novel strategies for protein vaccines
|
|
US8703095B2
(en)
*
|
2005-07-07 |
2014-04-22 |
Sanofi Pasteur S.A. |
Immuno-adjuvant emulsion
|
|
WO2007022152A2
(en)
*
|
2005-08-15 |
2007-02-22 |
The Research Foundation Of State University Of New York |
Lipid nano particulates containing antigens as cancer vaccines
|
|
CA2523032A1
(en)
|
2005-10-07 |
2007-04-07 |
Immunovaccine Technologies Inc. |
Vaccines for cancer therapy
|
|
WO2007067517A2
(en)
|
2005-12-07 |
2007-06-14 |
Hemispherx Biopharma |
Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants
|
|
JP5792920B2
(ja)
|
2005-12-22 |
2015-10-14 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
ワクチン
|
|
US8431160B2
(en)
*
|
2006-02-24 |
2013-04-30 |
Novartis Ag |
Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions
|
|
ES2356574T3
(es)
*
|
2006-02-24 |
2011-04-11 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Péptidos inmunogénicos y métodos de uso.
|
|
WO2007106536A2
(en)
*
|
2006-03-14 |
2007-09-20 |
Oregon Health & Science University |
Methods for producing an immune response to tuberculosis
|
|
EP2007357B1
(en)
|
2006-03-30 |
2016-11-09 |
The Research Foundation Of State University Of New York |
Compositions of less immunogenic and long-circulating protein-lipid complexes
|
|
KR20090024292A
(ko)
|
2006-06-28 |
2009-03-06 |
스태튼스 세룸 인스티튜트 |
단백질 단편 또는 펩타이드 혼합물로서 전달되는 항원을 가진 백신접종에 의해 준우성 항원결정기를 포함하는 ｔ세포 레퍼토리 확장
|
|
US20080014217A1
(en)
*
|
2006-07-17 |
2008-01-17 |
Emmanuel Jules Hanon |
Influenza vaccine
|
|
US8877206B2
(en)
*
|
2007-03-22 |
2014-11-04 |
Pds Biotechnology Corporation |
Stimulation of an immune response by cationic lipids
|
|
ES2588705T3
(es)
*
|
2007-09-27 |
2016-11-04 |
Immunovaccine Technologies Inc. |
Uso de liposomas en un vehículo que comprende una fase hidrófoba continua para la entrega de polinucleótidos in vivo
|
|
AU2008307042B2
(en)
|
2007-10-03 |
2014-01-30 |
Immunovaccine Technologies Inc. |
Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
|